Timosaponin AIII Suppresses RAP1 Signaling Pathway to Enhance the Inhibitory Effect of Paclitaxel on Nasopharyngeal Carcinoma

Although PTX has been identified as an effective drug for nasopharyngeal carcinoma (NPC) therapy, it has serious side effects in the human body. Previous studies have shown that timosaponin AIII (TSAIII) can inhibit the malignant progression of NPC cells. This study investigated the active mechanism...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiaofeng, Lu, Wen, Zhou, Tianjiao, Zhao, Feng, Yang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110172/
https://www.ncbi.nlm.nih.gov/pubmed/35586672
http://dx.doi.org/10.1155/2022/6756676

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110172/
https://www.ncbi.nlm.nih.gov/pubmed/35586672
http://dx.doi.org/10.1155/2022/6756676

Ejemplares similares